Pancreatic Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-01-23
Clinical Trial Update: Expanded Access to NanoPac
The expanded access program for NanoPac (paclitaxel nanoparticle formulation) has been discontinued and is no longer available.